TD Asset Management’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Hold |
47,788
| – | – | ﹤0.01% | 1157 |
|
|
2025
Q1 | $432K | Hold |
47,788
| – | – | ﹤0.01% | 1158 |
|
|
2024
Q4 | $826K | Hold |
47,788
| – | – | ﹤0.01% | 1133 |
|
|
2024
Q3 | $786K | Sell |
47,788
-23,520
| -33% | -$387K | ﹤0.01% | 1237 |
|
|
2024
Q2 | $1.02M | Hold |
71,308
| – | – | ﹤0.01% | 1156 |
|
|
2024
Q1 | $1.01M | Sell |
71,308
-47,946
| -40% | -$679K | ﹤0.01% | 1162 |
|
|
2023
Q4 | $1.8M | Hold |
119,254
| – | – | ﹤0.01% | 1039 |
|
|
2023
Q3 | $1.88M | Buy |
119,254
+59,627
| +100% | +$942K | ﹤0.01% | 973 |
|
|
2023
Q2 | $903K | Hold |
59,627
| – | – | ﹤0.01% | 1152 |
|
|
2023
Q1 | $865K | Hold |
59,627
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q4 | $806K | Buy |
59,627
+131
| +0.2% | +$1.77K | ﹤0.01% | 1185 |
|
|
2022
Q3 | $925K | Buy |
59,496
+1,821
| +3% | +$28.3K | ﹤0.01% | 1195 |
|
|
2022
Q2 | $702K | Hold |
57,675
| – | – | ﹤0.01% | 1240 |
|
|
2022
Q1 | $542K | Hold |
57,675
| – | – | ﹤0.01% | 1336 |
|
|
2021
Q4 | $987K | Buy |
+57,675
| New | +$987K | ﹤0.01% | 1275 |
|